{
    "title": "U.S. Supreme Court agrees to hear dispute over biologic drug sales",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4118432/U-S-Supreme-Court-agrees-hear-dispute-biologic-drug-sales.html",
    "date": "2017-01-13",
    "keywords": [
        "court",
        "drug",
        "amgen",
        "case",
        "dispute",
        "approval",
        "neupogen",
        "law",
        "brandname",
        "gmt",
        "appeal",
        "decision",
        "access",
        "sandoz",
        "zarxio",
        "biosimilar",
        "maker",
        "manufacturer",
        "email",
        "chungnew",
        "york",
        "jan",
        "ag",
        "company",
        "version",
        "incs",
        "food",
        "administration",
        "biosimilarsbiologic",
        "living",
        "brandsnovartis",
        "unit",
        "boost",
        "blood",
        "cell",
        "cancer",
        "fight",
        "infectionszarxio",
        "percent",
        "list",
        "patent",
        "infringement",
        "copycat",
        "versionin",
        "july",
        "circuit",
        "washington",
        "notice",
        "fda",
        "approvalnovartis",
        "exclusivity",
        "top",
        "healthcare",
        "costsif",
        "congress",
        "novartis",
        "petition",
        "casein",
        "statute",
        "innovation",
        "period",
        "december",
        "apotex",
        "inc",
        "amgenthe",
        "friday",
        "copy",
        "application",
        "fdathe",
        "v",
        "andrew",
        "chung"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}